Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net loss $ (748) $ (796) $ (1,723)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 21 21 22
Reduction in the carrying amount of right-of-use assets 28 27 28
Stock-based compensation 144 160 156
Goodwill impairment 0 0 1,114
Change in fair value of derivative liabilities 24 20 (114)
Accretion of discount on investments (28) (28) 0
Other operating activities (1) 0 (3)
Changes in operating assets and liabilities:      
Other current and non-current assets (22) 1 47
Operating lease liabilities (26) (25) (25)
Other current and non-current liabilities (3) 22 (10)
Net cash used in operating activities (611) (598) (508)
Cash flows from investing activities      
Purchases of property and equipment (34) (15) (15)
Purchases of investments (1,030) (1,297) (1,610)
Maturities of investments 892 1,320 773
Net cash (used in) provided by investing activities (172) 8 (852)
Cash flows from financing activities      
Proceeds from issuance of common stock 497 840 13
Other financing activities (5) (9) (2)
Net cash provided by financing activities 492 831 11
Net (decrease) increase in cash, cash equivalents, and restricted cash (291) 241 (1,349)
Cash, cash equivalents, and restricted cash at beginning of the period 518 277 1,626
Cash, cash equivalents, and restricted cash at end of the period $ 227 $ 518 $ 277